The GPIIIA PlA2 polymorphism is associated with an increased risk of cardiovascular adverse events

scientific article

The GPIIIA PlA2 polymorphism is associated with an increased risk of cardiovascular adverse events is …
instance of (P31):
scholarly articleQ13442814

External links are
P6179Dimensions Publication ID1029367584
P356DOI10.1186/1471-2261-10-41
P932PMC publication ID2954874
P698PubMed publication ID20846430
P5875ResearchGate publication ID46287604

P50authorSalvatore CasseseQ91597045
Federico PiscioneQ112583082
Guido IaccarinoQ56670390
Gennaro GalassoQ59164720
P2093author name stringBruno Trimarco
Gaetano Santulli
Raffaele Piccolo
Massimo Chiariello
Valentina Trimarco
Roberta De Rosa
P2860cites workPIA1/A2 polymorphism of platelet glycoprotein IIIa and risks of myocardial infarction, stroke, and venous thrombosisQ73073912
The GPIIIa Pl(A) polymorphism in the progression of abdominal aortic atherosclerosisQ73091569
Meta-analysis of the association of platelet glycoprotein IIIa PlA1/A2 polymorphism with myocardial infarctionQ73128810
Platelet GP IIIa Pl(A) polymorphisms display different sensitivities to agonistsQ73514248
Platelet glycoprotein IIb/IIIa Pl(A2)/Pl(A2) homozygosity associated with risk of ischemic cardiovascular disease and myocardial infarction in young men: the Copenhagen City Heart StudyQ73837005
PlA polymorphism of platelet glycoprotein IIIa and risk of restenosis after coronary stent placementQ74529476
Discussion: Reconsideration of TIA terminology and definitionsQ80000379
Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke TreatmentQ22306370
On the structure and function of platelet integrin alpha IIb beta 3, the fibrinogen receptorQ28287600
Final report on the aspirin component of the ongoing Physicians' Health StudyQ29619461
Platelet PlA2 polymorphism and thromboembolic events: from inherited risk to pharmacogeneticsQ33704606
The integrin alpha IIb/beta 3 in human platelet signal transductionQ34047199
The human platelet alloantigens, PlA1 and PlA2, are associated with a leucine33/proline33 amino acid polymorphism in membrane glycoprotein IIIa, and are distinguishable by DNA typingQ34573755
Mechanisms of disease: The genetic basis of coronary heart disease.Q36950890
Platelet activation and atherothrombosisQ37031278
The use of a telematic connection for the follow-up of hypertensive patients improves the cardiovascular prognosis.Q39719655
Platelet glycoprotein IIb/IIIa receptors in cardiovascular medicineQ40518648
Coronary morphologic and clinical determinants of procedural outcome with angioplasty for multivessel coronary disease. Implications for patient selection. Multivessel Angioplasty Prognosis Study GroupQ43765794
Effects of Ile164 polymorphism of beta2-adrenergic receptor gene on coronary artery disease.Q44088294
No evidence of association between prothrombotic gene polymorphisms and the development of acute myocardial infarction at a young age.Q44342380
The Pl(A1/A2) polymorphism of glycoprotein IIIa and cerebrovascular events in hypertension: increased risk of ischemic stroke in high-risk patients.Q48284904
Guidelines for the early management of patients with ischemic stroke: 2005 guidelines update a scientific statement from the Stroke Council of the American Heart Association/American Stroke AssociationQ48948869
A polymorphism of a platelet glycoprotein receptor as an inherited risk factor for coronary thrombosisQ51037257
Thrombolysis in Myocardial Infarction (TIMI) Trial, Phase I: A comparison between intravenous tissue plasminogen activator and intravenous streptokinase. Clinical findings through hospital dischargeQ54135542
Glycoprotein IIIa PlA1/A2 polymorphism and sudden cardiac deathQ57259861
ACC/AHA Guidelines for Percutaneous Coronary Intervention (Revision of the 1993 PTCA Guidelines)—Executive SummaryQ58975787
P921main subjectcirculatory systemQ11068
P304page(s)41
P577publication date2010-09-16
P1433published inBMC Cardiovascular DisordersQ15753126
P1476titleThe GPIIIA PlA2 polymorphism is associated with an increased risk of cardiovascular adverse events
P478volume10